Top Federal Drug Policy Expert Says Marijuana’s Schedule I Status Inhibits Research

Marijuana Moment
By Kyle JaegerApr 2, 2019, 5:18 pm121 pts
The head of a major federal drug policy agency acknowledged on Tuesday that the Schedule I status of marijuana and other drugs makes it “very difficult” for researchers to study the benefits and risks of those substances. Nora Volkow, director of the National Institute on Drug Abuse (NIDA), was asked how…

Read Article Share
Share Article
- email
- x.com
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

The case for a harmonized excise stamp: Why Ottawa’s easiest policy win is long overdue 64

A house divided: Why Canada’s cannabis industry must speak with one voice 49

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.